Gaush Meditech Ltd
HKEX:2407
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
G
|
Gaush Meditech Ltd
HKEX:2407
|
930.1m HKD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
202.2B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.4B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
148B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
124.9B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
113.5B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.8B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.7B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.3B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.3B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD |
Loading...
|
Market Distribution
| Min | -416 945.9% |
| 30th Percentile | -1.5% |
| Median | 3.5% |
| 70th Percentile | 8.9% |
| Max | 17 382.1% |
Other Profitability Ratios
Gaush Meditech Ltd
Glance View
Gaush Meditech Ltd. is an investment holding company, which engages in the provision of ophthalmic medical devices. The company is headquartered in Beijing, Beijing and currently employs 769 full-time employees. The company went IPO on 2022-12-12. The firm operates in four segments. Proprietary Products segment develops and produces surgical equipment and related supporting software, intra optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables. Distribution segment sells brand ophthalmic medical devices and consumables. Technical Services segment provides warranty service, maintenance service and consumables related to after-sales service. Others segment is mainly engaged in equipment leasing business and intellectual property agency services. The firm's products are widely used in the examination, treatment and correction of ophthalmic subspecialty diseases such as fundus disease, cataract, glaucoma, refraction, optometry, ocular surface, and children's ophthalmology.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Gaush Meditech Ltd is 7.1%, which is above its 3-year median of 3.8%.
Over the last 2 years, Gaush Meditech Ltd’s Net Margin has increased from -27.9% to 7.1%. During this period, it reached a low of -27.9% on Jan 1, 2023 and a high of 12.3% on Dec 31, 2023.
